These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
853 related articles for article (PubMed ID: 28493401)
1. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy. Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401 [TBL] [Abstract][Full Text] [Related]
2. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy? Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748 [TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T; Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer. Dinaux AM; Leijssen L; Bordeianou LG; Kunitake H; Amri R; Berger DL Surgery; 2018 Apr; 163(4):784-788. PubMed ID: 29277386 [TBL] [Abstract][Full Text] [Related]
5. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE). Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356 [TBL] [Abstract][Full Text] [Related]
6. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status. Kulaylat AS; Hollenbeak CS; Stewart DB Ann Surg Oncol; 2017 May; 24(5):1281-1288. PubMed ID: 27864695 [TBL] [Abstract][Full Text] [Related]
9. Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: a California Cancer Registry Study. Gill A; Brunson A; Lara P; Khatri V; Semrad TJ Eur J Surg Oncol; 2015 May; 41(5):647-52. PubMed ID: 25800934 [TBL] [Abstract][Full Text] [Related]
10. Impact of Surgical Complications Following Resection of Locally Advanced Rectal Adenocarcinoma on Adjuvant Chemotherapy Delivery and Survival Outcomes. Jamnagerwalla M; Tay R; Steel M; Keck J; Jones I; Faragher I; Gibbs P; Wong R Dis Colon Rectum; 2016 Oct; 59(10):916-24. PubMed ID: 27602922 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564 [TBL] [Abstract][Full Text] [Related]
12. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer. Madbouly KM; Hussein AM; Abdelzaher E Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience. Li F; Nielsen G; Baran A; Hu J; Wallace D; Preslar M; Fleming F; Temple L; Dunne RF; Noel M; Hezel AF; Tejani MA Clin Colorectal Cancer; 2020 Sep; 19(3):e124-e128. PubMed ID: 32409226 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer. Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients? Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer. Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589 [TBL] [Abstract][Full Text] [Related]
17. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599 [TBL] [Abstract][Full Text] [Related]
18. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605 [TBL] [Abstract][Full Text] [Related]
19. Does Adjuvant Chemotherapy for Locally Advanced Resectable Rectal Cancer treated with Neoadjuvant Chemoradiotherapy have an impact on survival? A Single Moroccan Institute Retrospective Study. Seddik Y; Brahmi SA; Afqir S Gulf J Oncolog; 2019 May; 1(30):29-32. PubMed ID: 31242979 [TBL] [Abstract][Full Text] [Related]
20. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases. Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]